Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma. [PDF]
Antibodies (Basel)Walsh GM.
europepmc +1 more source
Coronary Vasospasm in Eosinophilic Granulomatosis With Polyangiitis Presenting as Acute Coronary Syndrome Treated With Anti-IL-5. [PDF]
JACC Case RepThota P, Sharma S, Mohammed U.
europepmc +1 more source
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit. [PDF]
J Clin MedMartínez-Rivera C +12 more
europepmc +1 more source
Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review. [PDF]
Respir ResAegerter H +12 more
europepmc +1 more source
Clinical outcomes after switching from omalizumab to anti-IL-5/IL-5R biologics in severe asthma: a retrospective cohort study. [PDF]
BMC Pulm MedAkkuş FA +5 more
europepmc +1 more source
Applying Precision Medicine to the Heterogeneity of Asthma Attacks. [PDF]
ChestCelis-Preciado CA +6 more
europepmc +1 more source
Psychological and Related Factors Influencing Adherence to Biologic Therapies in Asthma: A Scoping Review. [PDF]
Curr Allergy Asthma RepPoletti V, Volpato E.
europepmc +1 more source
Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection. [PDF]
Front AllergyTondina E +8 more
europepmc +1 more source
Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2. [PDF]
Clin Exp AllergyPenz E +12 more
europepmc +1 more source
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation [PDF]
Vultaggio, Alessandra
core